ABSTRACT
Se presenta un caso clínico donde por complicación hemorrágica y proceso de tromboembolia pulmonar, se colocó un filtro de vena cava inferior bioconvertible. Se describen las características técnicas, el mecanismo de funcionamiento, las ventajas y las limitaciones de esta novedad tecnológica.(AU)
A clinical case is presented in which due to a hemorrhagic complication and a pulmonary thromboembolism, a bioconvertible inferior vena cava filter was placed in a patient. The technical characteristics, advantages and limitations of this technological innovation are described.(AU)
Subject(s)
Humans , Female , Aged , Endovascular Procedures , Vena Cava, Inferior , Vena Cava Filters , Pulmonary Embolism/complications , Treatment Outcome , Inpatients , Physical Examination , Symptom Assessment , Cardiovascular System , Blood VesselsABSTRACT
Hepatic sinusoidal obstruction syndrome (SOS) is a life-threatening complication with high mortality rate. Even if it is more commonly described after hematopoietic stem-cell transplant, hepatic-SOS may occur following the use of certain chemotherapeutic agents. Mitomycin-C has been previously identified as a causal agent when administered intravenously at high doses. We report herein the first case of hepatic-SOS due to intravesical instillation of mitomycin-C, after a traumatic urinary catheterization with significant hematuria. Although this procedure is usually considered safe, without the systemic side effects related to intravenous administration of the drug, clinicians must be aware of its potential risks to facilitate an early diagnosis, avoid a delay in the withdrawal of the causative drug and set up an appropriate therapy as soon as possible.
